GENE ONLINE|News &
Opinion
Blog

Gene Therapy
Revolutionizing Eye Disease Treatment with iPSC Therapy
2023-03-07
Global Head of Research of Kite Pharma Unveiled the Key Elements to Success in Adoptive Cell Therapy
2023-03-07
CSL’s Hemgenix Wins First Gene Therapy Approval For Hemophilia In Europe
2023-02-21
Immusoft’s B Cell Gene Therapy Gets FDA Nod to Enter Clinical Trials
2023-02-13
Patent Landscape Analysis of Gene Therapy
2023-02-08
EMA Plans to Issue Liver Failure Warning for Novartis’ Gene Therapy
2023-01-16
Will Breakthrough Therapy Lead the Way? An Overview of the Approved Gene and Cell Therapies for 2022
2023-01-13
Hemgenix Marks Most Expensive Treatment Ever and First Gene Therapy for Hemophilia B
2022-11-22
Astellas Invests $50 Million In Taysha, Licenses Two CNS Gene Therapies
2022-10-25
Eli Lilly Snatches Up Akouos Treating Ear Conditions for $487 million
2022-10-18
FDA Accepts Resubmission of BioMarin’s Gene Therapy Two Years After Rejection
2022-10-13
Pfizer Opts In On Neurological Target In Voyager Deal, Leaving $290 Million In Milestones
2022-10-05
Sarepta Submits BLA for First-Ever Duchenne Muscular Dystrophy Gene Therapy
2022-10-03
A New Sequencer on the Horizon – Illumina Genomics Forum Days Two and Three Highlights
2022-09-30
Illumina Genomics Forum Kicks Off With A Conversation With President Barack Obama
2022-09-29
1 2 3 9
LATEST
Pfizer’s RSV Vaccine Gets FDA Approval for Use in Older Adults
2023-05-31
Brazil’s Evolving ESG Landscape from the Amazon to Atlantic Forest
2023-05-31
Should People Looking to Lose Weight Skip Sugar Substitutes?
2023-05-30
Advancing Next-Generation Cancer Metabolic Therapy by Targeting Critical Amino Acid Metabolic Pathways: An Interview with Brian A. Van Tine, MD, PhD
2023-05-26
Rona Therapeutics, Keymed Biosciences Team Up To Develop siRNA Drugs For Kidney Disease
2023-05-25
CDC Calls an End to J&J’s COVID-19 Vaccine in the U.S.
2023-05-25
A Close Look at the Evolution of ESG in Biopharma
2023-05-22
Scroll to Top